ALISA VIEJO, CA — May 1, 2023 — ViaLase, Inc., a clinical stage medical technology company focused on addressing unmet needs in the conventional glaucoma treatment paradigm with the development of a truly noninvasive image-guided femtosecond laser treatment to enhance glaucoma patient care, today announced that it will present first-in-human clinical data and a technology […] The post ViaLase to Present Clinical Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting appeared first on Vialase .